Barret Murphy
Internal Medicine · Baton Rouge, LANPI 1174057053
Payments from drug & device makers
What this record shows
This record is dominated by grants: $31,375 of the $42,900 with a category attached, or 73.1%. Abbott accounts for 61.2% of it on its own, with 25 other manufacturers making up the rest. Among internal medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $188.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$26K
- Medtronic$11K
- Boston Scientific$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$712
- Johnson & Johnson$480
- Biosense Webster, Inc.$430
- plus $2K from 20 others
What the payments were for
- Grants$31,37573%
- Travel & lodging$3,5498%
- Food & beverage$7,38817%
- Education$5881%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 68 | $26,254 |
| Medtronic | 14 | $10,990 |
| Boston Scientific | 12 | $1,909 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $712 |
| Johnson & Johnson | 17 | $480 |
| Biosense Webster, Inc. | 10 | $430 |
| Novartis | 18 | $363 |
| AstraZeneca | 12 | $262 |
| Pfizer | 11 | $187 |
| Amgen | 9 | $166 |
| Novo Nordisk | 6 | $154 |
| Abiomed | 4 | $145 |
| Boehringer Ingelheim | 6 | $135 |
| Kestra Medical Technology Services, Inc. | 6 | $135 |
| Pacira Pharmaceuticals Incorporated | 1 | $124 |
| E.r. Squibb & Sons, L.L.C. | 6 | $108 |
| Alnylam Pharmaceuticals Inc. | 3 | $77 |
| Livanova USA, Inc. | 2 | $72 |
| Biotronik Inc. | 3 | $58 |
| Lexicon Pharmaceuticals, Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Lantheus Medical Imaging, Inc. | 1 | $24 |
| Cook Medical LLC | 1 | $18 |
| Philips North America LLC | 1 | $16 |
| Bayer | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASSURITY$7,875
- ENSITE PRECISION$1,720
- WATCHMAN Access System$1,535
- ENSITE$1,356
- Micra$237
- XARELTO$221
- OMNIASECURE MRI SURESCAN$152
- Carto 3$133
- AURORA EV-ICD MRI SURESCAN$125
- EXPAREL$124
- HeartMate 3 Left Ventricular Assist Device$118
- LifeVest$116
- AZURE XT DR MRI SURESCAN$111
- CLARIA MRI QUAD CRT-D SURESCAN$107
How this compares
$42,900 in reported general payments places this provider in the 95th percentile of 1,528 internal medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $49,900 |
| JardianceEmpagliflozin | 55 | $48,792 |
| EntrestoSacubitril/Valsartan | 53 | $46,491 |
| MultaqDronedarone Hcl | 12 | $10,617 |
| Repatha SureclickEvolocumab | 12 | $8,682 |
| Valsartan | 24 | $930 |
| Metoprolol Succinate | 51 | $692 |
| Atorvastatin Calcium | 42 | $404 |
| Amiodarone Hcl | 22 | $393 |
| ClopidogrelClopidogrel Bisulfate | 21 | $342 |
| Sucralfate | 12 | $331 |
| Pantoprazole Sodium | 49 | $201 |
| Doxycycline Hyclate | 48 | $157 |
| Spironolactone | 20 | $146 |
| Rosuvastatin Calcium | 11 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $187 | $49,90042 claims |
| Boehringer IngelheimJardiance | $135 | $48,79255 claims |
| NovartisEntresto | $363 | $46,49153 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,528 internal medicine providers in Louisiana.
Other internal medicine in Baton Rouge
- Donna RyanBaton Rouge$991K
- John SchwabBaton Rouge$122K
- Brian GremillionBaton Rouge$27K
- Bradley MeekBaton Rouge$20K
- Leo BlaizeBaton Rouge$17K
- Michael HymbaughBaton Rouge$16K
- Kyle ChampagneBaton Rouge$16K
- Charles HalliburtonBaton Rouge$16K
- Hartman BruntBaton Rouge$15K
- Lauren BarfieldBaton Rouge$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.